AGTC CEO to present at Cell & Gene Meeting on the Mesa
By The Science Advisory Board staff writersOctober 12, 2021
AGTC conducts human clinical trials of adeno-associated virus-based gene therapies for the treatment of rare inherited retinal diseases.
Washer will provide a corporate update and talk about AGTC's plans to move late-stage X-linked retinitis pigmentosa and achromatopsia clinical programs forward, the company said.